Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds specifically-identified oligosaccharide structure
Patent
1994-12-30
1999-03-02
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds specifically-identified oligosaccharide structure
4241481, 4241531, 4241541, 4241551, 435 7021, 435329, 4353391, 4353431, 435343, 4353432, 435344, 435451, 435452, 53038835, 5303875, 5303887, 53038873, 53038875, 5303888, A61K 3942, C07K 1628, C07K 1630, C07K 1610
Patent
active
058767169
ABSTRACT:
A monoclonal or other antibody to the carbohydrate antigen Tn can be used to inhibit or slow the progression of AIDS or ARC. The antigen can be used in a vaccine, for immunisation.
REFERENCES:
Zolla-Pazner et al. J. Virol Mtds 17:45-53, 1987.
Fahey et al., Clin Exp. Immunol. 88:1-5 1992.
Hansen et al. J. Virology 64:2833-2840, 1990.
Hansen et al. J. Virology 65:6461-6467, 1991.
Harris et al. Tibtech 11:42-44, 1993.
Kjelcken et al. Cancer Res. 48:2214-2220 1988.
Aguila et al. Immunochemica vol. II (2) pp. 1-4, Jun. 1988.
Cooper, "The Tools of Biochemistry", John Wiley + Sons, 1977, pp. 378-385.
Clausen Henrik
Hansen John-Erik Stig
Bay Development Corporation SA
Caputa Anthony C.
LandOfFree
Method of using an antibody to the TN antigen for the inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using an antibody to the TN antigen for the inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using an antibody to the TN antigen for the inhibition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-419706